Option Care Health price target raised to $38 from $35 at Barrington

Barrington raised the firm’s price target on Option Care Health to $38 from $35 and keeps an Outperform rating on the shares after the company reported “strong” Q4 results. While initial FY24 guidance was as expected, the firm sees “many reasons to believe” that Option Care could ultimately deliver an adjusted EBITDA result closer to the high end of the range.